ONCE-DAILY INHALED UMECLIDINIUM/VILANTEROL COMBINATION THERAPY COMPARED WITH PLACEBO ON EXACERBATIONS IN CHINESE PATIENTS WITH COPD

被引：0
|
作者：
Zheng, Jinping [1 ]
Goh, Aik [2 ]
Huang, Chunchen [2 ]
Luo, Xian [2 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[2] GlaxoSmithKline, Shanghai, Peoples R China
来源：
RESPIROLOGY | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO110
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study
    Zheng, Jinping
    Zhong, Nanshan
    Newlands, Amy
    Church, Alison
    Goh, Aik H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1753 - 1767
  • [2] Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD A Randomized, Controlled Study
    Celli, Bartolome
    Crater, Glenn
    Kilbride, Sally
    Mehta, Rashmi
    Tabberer, Maggie
    Kalberg, Chris J.
    Church, Alison
    CHEST, 2014, 145 (05) : 981 - 991
  • [3] Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
    Donohue, J. F.
    Maleki-Yazdi, M. R.
    Kilbride, S.
    Mehta, R.
    Kalberg, C.
    Church, A.
    RESPIRATORY MEDICINE, 2013, 107 (10) : 1538 - 1546
  • [4] EFFECT OF ONCE-DAILY SINGLE-INHALER FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL TRIPLE THERAPY ON EXACERBATIONS COMPARED WITH BUDESONIDE/FORMOTEROL DUAL THERAPY IN PATIENTS WITH COPD AND NO HISTORY OF EXACERBATIONS: A POST HOC ANALYSIS OF THE FULFIL STUDY
    Panettieri, Reynold
    Bangalore, Mohan
    Camargo, Carlos
    Cheema, Tariq
    El Bayadi, Sherif
    Fiel, Stanley
    Jain, Renu
    Midwinter, Dawn
    Rabadi, Nashat
    Thomashow, Byron
    Lipson, David
    CHEST, 2021, 160 (04) : 1822A - 1825A
  • [5] Anoro Ellipta: An Inhaled Umeclidinium/Vilanterol Combination for COPD
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1440): : 30 - 31
  • [6] Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study
    Zhong, Nanshan
    Zheng, Jinping
    Lee, Sang Haak
    Lipson, David A.
    Du, Xin
    Wu, Shunquan
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 809 - 819
  • [7] EFFICACY AND SAFETY OF ONCE-DAILY INHALED UMECLIDINIUM IN ASIAN PATIENTS WITH COPD: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Zheng, Jinping
    Huang, Chunchen
    Luo, Xian
    Du, Xin
    RESPIROLOGY, 2018, 23 : 133 - 133
  • [8] Umeclidinium/vilanterol (UMEC/VI) once daily (OD) vs fluticasone/salmeterol combination (FSC) twice daily (BD) in patients with moderate-to-severe COPD and infrequent COPD exacerbations
    Singh, D.
    Worsley, S.
    Zhu, C-Q
    Hardaker, L.
    Church, A.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [9] EFFECT OF AGE ON EFFICACY AND SAFETY OF ONCE-DAILY UMECLIDINIUM IN PATIENTS WITH COPD
    Soule, Tedi
    Caveney, Scott
    Tombs, Lee
    Naya, Ian
    Boucot, Isabelle
    CHEST, 2018, 154 (04) : 750A - 750A
  • [10] Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
    Amanda J. Oliver
    Ronina A. Covar
    Caroline H. Goldfrad
    Ryan M. Klein
    Søren E. Pedersen
    Christine A. Sorkness
    Susan A. Tomkins
    César Villarán
    Jonathan Grigg
    Respiratory Research, 17
12345